+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Hemostasis/Coagulation Analyzers Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026

  • ID: 4620341
  • Report
  • August 2018
  • Region: Global
  • Acute Market Reports
1 of 3

FEATURED COMPANIES

  • Beckman Coulter Inc.
  • F-Hoffmann La Roche
  • Nihon Kohden Corporation
  • Sysmex Corporation
  • MORE
Hemostasis/Coagulation Analyzers Market - Growth, Future Prospects, Competitive Analysis, 2018 - 2026, the global hemostasis/coagulation analyzers market was valued at US$ 3,650.1 Mn in 2017 and expected to reach US$ 9,548.0 Mn by 2026, expanding at a CAGR of 9.9% from 2018 to 2026.

Market Insights
Growing incidence of blood disorders is mainly attributed to the growth of hemostasis analyzers market. Hemostasis/coagulation tests are ideally performed for three reasons: disorder diagnosis, screening for coagulation disorders and therapy monitoring. Hemostasis tests are performed on almost every hospitalized patient, as bleeding history is the most reliable predictor of bleeding risk in any procedure. Hemostasis analyzers assist in treating patients with bleeding disorders and abnormal blood clotting. Perpetual innovation in technology and miniaturization has led to commercialization of many novel devices that have quick turnaround time and also can be used in point of care settings. Furthermore, growing awareness and demand for technologically advanced medical treatments, support from governments and growing adoption of laboratory automation urges the demand for novel coagulation analyzers.

The global hemostasis/coagulation analyzers market is segmented based on test types, product types, and end users. Among the test types, routine coagulation tests occupy the largest share of the global market. A large number of these tests being performed for almost all surgical procedures and treatments mainly assists in the dominance of this segment. Growing adoption of specific tests such as VWF assays and thrombophilia testing in the light of growing awareness and prevalence of coagulation disorders will facilitate faster growth rate to diagnostic hemostasis assays segment. Currently, between devices (analyzers) and consumables, the former segment holds larger revenue share globally. Higher cost and consistently growing purchase of these systems both in laboratory and point of care settings are attributed to the prominence of devices segment.

Based on end users, the global hemostasis/coagulation analyzers market is studied for hospitals & clinics, diagnostic laboratories, and research institutions. Among these, the diagnostic laboratories segment dominated the global market. Greater preference of analyzing samples in specialized laboratories mainly drives this segment. The uptake of hemostasis analyzers is high in research institutions due to the surge in the number of clinical trials being undertaken for treatment development and innovating diagnostic solutions.

In 2017, North America dominated the global hemostasis analyzers market in terms of revenue, due to the existence of developed healthcare infrastructure, a multitude of R&D initiatives, a high number of organ transplant and general surgeries being performed in the region and so on. On the other hand, Asia Pacific region will witness the fastest growth on the global front. Growing awareness about hemostasis, increasing disease prevalence both genetic and lifestyle linked and increasing healthcare expenditure are the major drivers of this regional market.

The competitive front of the hemostasis industry is intense and is characterized by the presence of several multinational players. The major market players have intensified their R&D efforts towards the development of technologically advanced and more accurate analyzers. They are also undertaking penetration measures to enter the untapped markets of the Asia Pacific and Middle East & Africa. Some of the key players engaged in the global hemostasis/coagulation analyzers market are Alere Inc. (Abbott Laboratories, Inc.), F-Hoffmann La Roche, Sysmex Corporation, Beckman Coulter, Inc. (Danaher), Nihon Kohden Corporation, Thermo Fisher Scientific Inc., Siemens Healthcare (Siemens AG), International Technidyne Corporation (Werfen), and Beckman Coulter Inc.

Key Market Movements:
  • Growing incidence of hematological diseases and increasing preference for coagulation tests in all surgical procedures
  • The rapid evolution of healthcare infrastructure in untapped markets of Asia Pacific
  • Growing preference for novel compact and automatic analyzers that can be used in point of care settings
  • Growing efforts to commercialize novel drugs for the treatment of coagulation disorders
  • Rapid penetration of major market players in the emerging regions and Asia Pacific, parts of Latin America and Middle East & Africa
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Beckman Coulter Inc.
  • F-Hoffmann La Roche
  • Nihon Kohden Corporation
  • Sysmex Corporation
  • MORE
Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Market Segmentation
1.3. Research Scope
1.4. Research Methodology
1.4.1. Phase I – Secondary Research
1.4.2. Phase II – Primary Research
1.4.3. Phase III – Expert Panel Review
1.4.4. Assumptions
1.5. Market Segmentation

Chapter 2. Executive Summary
2.1. Global Hemostasis/Coagulation Analyzers Market Portraiture
2.2. Global Hemostasis/Coagulation Analyzers Market, by Test, 2017 (US$ Mn)
2.3. Global Hemostasis/Coagulation Analyzers Market, by Product, 2017 (US$ Mn)
2.4. Global Hemostasis/Coagulation Analyzers Market, by End User, 2017 (US$ Mn)
2.5. Global Hemostasis/Coagulation Analyzers Market, by Geography, 2017 (US$ Mn)

Chapter 3. Global Hemostasis/Coagulation Analyzers Market: Dynamics and Future Outlook
3.1. Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Hemostasis/Coagulation Analyzers Market, by Key Players, 2017

Chapter 4. Global Hemostasis/Coagulation Analyzers Market, by Test, 2016-2026 (US$ Mn)
4.1. Overview
4.2. Routine Coagulation Tests
4.2.1. Prothrombin Time (PT)
4.2.2. International Normalized Ratio (INR)
4.2.3. Activated Partial Thromboplastin Time (APTT)
4.2.4. Thrombin Time (TT)
4.2.5. Fibrinogen
4.2.6. D-dimer
4.3. Diagnostic Hemostasis Assays
4.3.1. VWF Assays
4.3.2. Platelet Function Testing
4.3.3. Thrombophilia Testing
4.3.4. Factor Inhibitors
4.3.5. Factor Assays

Chapter 5. Global Hemostasis/Coagulation Analyzers Market, by Product, 2016-2026 (US$ Mn)
5.1. Overview
5.2. Consumables
5.2.1. Reagents
5.2.2. Strips, Standards, Controls, Calibrations, etc.
5.3. Devices
5.3.1. Clinical Laboratory Analyzers
5.3.2. Point of Care Analyzers

Chapter 6. Global Hemostasis/Coagulation Analyzers Market, by End User, 2016-2026 (US$ Mn)
6.1. Overview
6.2. Hospitals & Clinics
6.3. Diagnostic Laboratories
6.4. Clinical laboratories & Research Institutions

Chapter 7. Global Hemostasis/Coagulation Analyzers Market, by Geography, 2016 – 2026 (US$ Mn)
7.1. Overview
7.1.1. North America Hemostasis/Coagulation Analyzers Market, 2016-2026 (US$ Mn)
7.1.2. North America Hemostasis/Coagulation Analyzers Market, by Test, 2016 - 2026 (US$ Mn)
7.1.3. North America Hemostasis/Coagulation Analyzers Market, by Product, 2016 - 2026 (US$ Mn)
7.1.4. North America Hemostasis/Coagulation Analyzers Market, by End User, 2016 - 2026 (US$ Mn)
7.1.5. North America Hemostasis/Coagulation Analyzers Market, by Country, 2016 – 2026 (US$ Mn)
7.1.5.1. U.S.
7.1.5.2. Canada
7.2. Europe Hemostasis/Coagulation Analyzers Market, 2016 – 2026 (US$ Mn)
7.2.1. Europe Hemostasis/Coagulation Analyzers Market, by Test, 2016 - 2026 (US$ Mn)
7.2.2. Europe Hemostasis/Coagulation Analyzers Market, by Product, 2016 - 2026 (US$ Mn)
7.2.3. Europe Hemostasis/Coagulation Analyzers Market, by End User, 2016 - 2026 (US$ Mn)
7.2.4. Europe Hemostasis/Coagulation Analyzers Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.2.4.1. U.K.
7.2.4.2. Germany
7.2.4.3. Rest of Europe
7.3. Asia Pacific Hemostasis/Coagulation Analyzers Market, 2016 – 2026 (US$ Mn)
7.3.1. Asia Pacific Hemostasis/Coagulation Analyzers Market, by Test, 2016 - 2026 (US$ Mn)
7.3.2. Asia Pacific Hemostasis/Coagulation Analyzers Market, by Product, 2016 - 2026 (US$ Mn)
7.3.3. Asia Pacific Hemostasis/Coagulation Analyzers Market, by End User, 2016 - 2026 (US$ Mn)
7.3.4. Asia Pacific Hemostasis/Coagulation Analyzers Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.3.4.1. China
7.3.4.2. Japan
7.3.4.3. Rest of Asia Pacific
7.4. Latin America Hemostasis/Coagulation Analyzers Market, 2016 – 2026 (US$ Mn)
7.4.1. Latin America Hemostasis/Coagulation Analyzers Market, by Test, 2016 - 2026 (US$ Mn)
7.4.2. Latin America Hemostasis/Coagulation Analyzers Market, by Product, 2016 - 2026 (US$ Mn)
7.4.3. Latin America Hemostasis/Coagulation Analyzers Market, by End User, 2016 - 2026 (US$ Mn)
7.4.4. Latin America Hemostasis/Coagulation Analyzers Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.4.4.1. Brazil
7.4.4.2. Mexico
7.4.4.3. Rest of Latin America
7.5. Middle East & Africa Hemostasis/Coagulation Analyzers Market, 2016 – 2026 (US$ Mn)
7.5.1. Middle East & Africa Hemostasis/Coagulation Analyzers Market, by Test, 2016 - 2026 (US$ Mn)
7.5.2. Middle East & Africa Hemostasis/Coagulation Analyzers Market, by Product, 2016 - 2026 (US$ Mn)
7.5.3. Middle East & Africa Hemostasis/Coagulation Analyzers Market, by End User, 2016 - 2026 (US$ Mn)
7.5.4. Middle East & Africa Hemostasis/Coagulation Analyzers Market, by Region, 2016 – 2026 (US$ Mn)
7.5.4.1. GCC
7.5.4.2. Rest of Middle East & Africa

Chapter 8. Company Profiles
8.1. Alere Inc. (Abbott Laboratories, Inc.)
8.1.1. Business Description
8.1.2. Financial Information (Subject to Data Availability)
8.1.3. Product Portfolio
8.1.4. Key Developments
8.2. F-Hoffmann La Roche
8.3. Sysmex Corporation
8.4. Beckman Coulter, Inc. (Danaher)
8.5. Nihon Kohden Corporation
8.6. Thermo Fisher Scientific Inc.
8.7. Siemens Healthcare (Siemens AG)
8.8. International Technidyne Corporation (Werfen)
8.9. Beckman Coulter Inc.

List of Figures:
Figure 1. Hemostasis/Coagulation Analyzers Market: Research Methodology
Figure 2. Hemostasis/Coagulation Analyzers: Market Segmentation
Figure 3. Global Hemostasis/Coagulation Analyzers Market, by Test, 2017 (US$ Mn)
Figure 4. Global Hemostasis/Coagulation Analyzers Market, by Product, 2017 (US$ Mn)
Figure 5. Global Hemostasis/Coagulation Analyzers Market, by End User, 2017 (US$ Mn)
Figure 6. Global Hemostasis/Coagulation Analyzers Market, by Geography, 2017 (US$ Mn)
Figure 7. Attractive Investment Proposition, by Geography, 2017
Figure 8. Competitive Analysis: Global Hemostasis/Coagulation Analyzers Market, by Key Players, 2017
Figure 9. Global Prothrombin Time (PT) Tests Market, 2016-2026(US$ Mn)
Figure 10. Global International Normalized Ratio (INR) Tests Market, 2016-2026 (US$ Mn)
Figure 11. Global Activated Partial Thromboplastin Time (APTT) Tests Market, 2016-2026 (US$ Mn)
Figure 12. Global Thrombin Time (TT) Tests Market, 2016-2026 (US$ Mn)
Figure 13. Global Fibrinogen Tests Market, 2016-2026 (US$ Mn)
Figure 14. Global D-dimer Tests Market, 2016-2026 (US$ Mn)
Figure 15. Global VWF Assays Tests Market, 2016-2026 (US$ Mn)
Figure 16. Global Platelet Function Testing Market, 2016-2026 (US$ Mn)
Figure 17. Global Thrombophilia Testing Market, 2016-2026 (US$ Mn)
Figure 18. Global Factor Inhibitors Tests Market, 2016-2026 (US$ Mn)
Figure 19. Global Factor Assays Tests Market, 2016-2026 (US$ Mn)
Figure 20. Global Hemostasis/Coagulation Test Reagents Market, 2016-2026 (US$ Mn)
Figure 21. Global Hemostasis/Coagulation Test Strips, Standards, Controls, Calibrations, etc. Market, 2016-2026 (US$ Mn)
Figure 22. Global Hemostasis/Coagulation Clinical Laboratory Analyzers Market, 2016-2026 (US$ Mn)
Figure 23. Global Hemostasis/Coagulation Point of Care Analyzers Market, 2016-2026 (US$ Mn)
Figure 24. Global Hemostasis/Coagulation Analyzers Market for Hospitals & Clinics, 2016-2026 (US$ Mn)
Figure 25. Global Hemostasis/Coagulation Analyzers Market for Diagnostic Laboratories, 2016-2026 (US$ Mn)
Figure 26. Global Hemostasis/Coagulation Analyzers Market for Clinical laboratories & Research Institutions, 2016-2026 (US$ Mn)
Figure 27. U.S. Hemostasis/Coagulation Analyzers Market, 2016-2026 (US$ Mn)
Figure 28. Canada Hemostasis/Coagulation Analyzers Market, 2016-2026 (US$ Mn)
Figure 29. U.K. Hemostasis/Coagulation Analyzers Market, 2016-2026 (US$ Mn)
Figure 30. Germany Hemostasis/Coagulation Analyzers Market, 2016-2026 (US$ Mn)
Figure 31. Rest of Europe Hemostasis/Coagulation Analyzers Market, 2016-2026 (US$ Mn)
Figure 32. China Hemostasis/Coagulation Analyzers Market, 2016-2026 (US$ Mn)
Figure 33. Japan Hemostasis/Coagulation Analyzers Market, 2016-2026 (US$ Mn)
Figure 34. Rest of Asia Pacific Hemostasis/Coagulation Analyzers Market, 2016-2026 (US$ Mn)
Figure 35. Brazil Hemostasis/Coagulation Analyzers Market, 2016-2026 (US$ Mn)
Figure 36. Mexico Hemostasis/Coagulation Analyzers
Figure 37. Market, 2016-2026 (US$ Mn)
Figure 38. Rest of Latin America Hemostasis/Coagulation Analyzers Market, 2016-2026 (US$ Mn)
Figure 39. GCC Hemostasis/Coagulation Analyzers Market, 2016-2026 (US$ Mn)
Figure 40. Rest of Middle East and Africa Hemostasis/Coagulation Analyzers Market, 2016-2026 (US$ Mn)

List of Tables:
Table 1 Global Hemostasis/Coagulation Analyzers Market Portraiture
Table 2 Global Hemostasis/Coagulation Analyzers Market, by Test, 2016 – 2026 (US$ Mn)
Table 3 Global Hemostasis/Coagulation Analyzers Market, by Routine Coagulation Tests, 2016 – 2026 (US$ Mn)
Table 4 Global Hemostasis/Coagulation Analyzers Market, by Diagnostic Hemostasis Assays, 2016 – 2026 (US$ Mn)
Table 5 Global Hemostasis/Coagulation Analyzers Market, by Product, 2016 – 2026 (US$ Mn)
Table 6 Global Hemostasis/Coagulation Analyzers Market, by Consumables, 2016 – 2026 (US$ Mn)
Table 7 Global Hemostasis/Coagulation Analyzers Market, by Devices, 2016 – 2026 (US$ Mn)
Table 8 Global Hemostasis/Coagulation Analyzers Market, by Geography, 2016 – 2026 (US$ Mn)
Table 9 North America Hemostasis/Coagulation Analyzers Market, by Test, 2016 – 2026 (US$ Mn)
Table 10 North America Hemostasis/Coagulation Analyzers Market, by Product, 2016 – 2026 (US$ Mn
Table 11 North America Hemostasis/Coagulation Analyzers Market, by End User, 2016 – 2026 (US$ Mn
Table 12 North America Hemostasis/Coagulation Analyzers Market, by Country, 2016 – 2026 (US$ Mn)
Table 13 Europe Hemostasis/Coagulation Analyzers Market, by Test, 2016 – 2026 (US$ Mn)
Table 14 Europe Hemostasis/Coagulation Analyzers Market, by Product, 2016 – 2026 (US$ Mn)
Table 15 Europe Hemostasis/Coagulation Analyzers Market, by End User, 2016 – 2026 (US$ Mn)
Table 16 Europe Hemostasis/Coagulation Analyzers Market, by Country/Region, 2016 – 2026 (US$ Mn)
Table 17 Asia Pacific Hemostasis/Coagulation Analyzers Market, by Test, 2016 – 2026 (US$ Mn)
Table 18 Asia Pacific Hemostasis/Coagulation Analyzers Market, by Product, 2016 – 2026 (US$ Mn)
Table 19 Asia Pacific Hemostasis/Coagulation Analyzers Market, by End User, 2016 – 2026 (US$ Mn)
Table 20 Asia Pacific Hemostasis/Coagulation Analyzers Market, by Country/Region, 2016 – 2026 (US$ Mn)
Table 21 Latin America Hemostasis/Coagulation Analyzers Market, by Test, 2016 – 2026 (US$ Mn)
Table 22 Latin America Hemostasis/Coagulation Analyzers Market, by Product, 2016 – 2026 (US$ Mn
Table 23 Latin America Hemostasis/Coagulation Analyzers Market, by End User, 2016 – 2026 (US$ Mn
Table 24 Latin America Hemostasis/Coagulation Analyzers Market, by Country/Region, 2016 – 2026 (US$ Mn)
Table 25 Middle East and Africa Hemostasis/Coagulation Analyzers Market, by Test, 2016 – 2026 (US$ Mn)
Table 26 Middle East and Africa Hemostasis/Coagulation Analyzers Market, by Product, 2016 – 2026 (US$ Mn)
Table 27 Middle East and Africa Hemostasis/Coagulation Analyzers Market, by End User, 2016 – 2026 (US$ Mn)
Table 28 Middle East and Africa Hemostasis/Coagulation Analyzers Market, by Region, 2016 – 2026 (US$ Mn)
Table 29 Alere Inc. (Abbott Laboratories, Inc.): Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 30 F-Hoffmann La Roche: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 31 Sysmex Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 32 Beckman Coulter, Inc. (Danaher): Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 33 Nihon Kohden Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 34 Thermo Fisher Scientific Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 35 Siemens Healthcare (Siemens AG): Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 36 International Technidyne Corporation (Werfen): Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Table 37 Beckman Coulter Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
Note: Product cover images may vary from those shown
3 of 3
  • Alere Inc. (Abbott Laboratories, Inc.)
  • F-Hoffmann La Roche
  • Sysmex Corporation
  • Beckman Coulter, Inc. (Danaher)
  • Nihon Kohden Corporation
  • Thermo Fisher Scientific Inc.
  • Siemens Healthcare (Siemens AG)
  • International Technidyne Corporation (Werfen)
  • Beckman Coulter Inc.
Note: Product cover images may vary from those shown
Adroll
adroll